Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Corning Announces Significant Milestone in High-Throughput Label-Free Screening for Drug Development.


Two 100,000-compound screens performed in high throughput using Corning[R] Epic[R] System;

Data presented at industry's first label-free symposium in Dresden, Germany

CORNING, N.Y. -- Corning Incorporated Corning Incorporated NYSE: GLW is an American manufacturer of glass, ceramics and related materials, primarily for industrial and scientific applications. The company was known until 1989 as Corning Glass Works.  (NYSE NYSE

See: New York Stock Exchange
:GLW GLW Glasgow Airport (UK)
GLW Gross Laden Weight
GLW Good Lady Wife (Australia) 
) today announced the completion of two independent high-throughput label-free screens believed to be the largest ever publicly announced label-free screens to date. Renowned scientists from two of the top 10 pharmaceutical companies each screened 100,000 drug candidates in high throughput using the label-free Corning[R] Epic[R] System. These two screens represent a major milestone in accelerating drug discovery using label-free technology.

"Our customers have demonstrated true high-throughput label-free screening - a goal that has eluded label-free researchers for many years," said Ron Verkleeren, Epic business director, Corning Incorporated. "Removing fluorescent, luminescent lu·mi·nes·cent  
adj.
Capable of, suitable for, or exhibiting luminescence.



[Latin lmen, l
 and radioactive labels from assays promises to improve the speed and quality of the drug discovery process," he continued. "It can open up a wider variety of drug targets and enable researchers to study drug candidates in more physiologically relevant systems. These screens exemplify the remarkable progress label-free technology has made in the last few years and the significant impact it can have in the future."

Data from both screens were presented at the Label Free Technologies in Drug Discovery Symposium hosted by the Society for Biomolecular Sciences (SBS See Small Business Server. ) from June 10-11 in Dresden, Germany. For further information about the presentations or the SBS Label Free symposium visit http://www.sbsonline.org/events/symposia/2008_dresden/.

Corning's Epic system is the world's first high-throughput label-free screening system. It uses patented optical biosensor A device that detects and analyzes body movement, temperature or fluids and turns it into an electronic signal. See lab on a chip and data glove.
Biosensor 
 technology to enable the study of a broad range of biochemical and cell-based targets. The system was launched in 2006 and has been deployed at customer sites in North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. , Europe and Asia.

For additional information on the Epic System or any other Corning Life Sciences products, please contact a customer service representative at 1-800-492-1110, toll-free in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , (+1) 978-442-2200 internationally, or visit www.corning.com/epic.

About Corning Incorporated

Corning Incorporated (www.corning.com) is the world leader in specialty glass and ceramics. Drawing on more than 150 years of materials science materials science

Study of the properties of solid materials and how those properties are determined by the material's composition and structure, both macroscopic and microscopic.
 and process engineering knowledge, Corning creates and makes keystone components that enable high-technology systems for consumer electronics, mobile emissions control, telecommunications and life sciences. Our products include glass substrates for LCD televisions, computer monitors and laptops; ceramic substrates and filters for mobile emission control systems; optical fiber, cable, hardware & equipment for telecommunications networks; optical biosensors for drug discovery; and other advanced optics and specialty glass solutions for a number of industries including semiconductor, aerospace, defense, astronomy and metrology.
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 12, 2008
Words:428
Previous Article:Opexa Therapeutics Reports Favorable Two-Year Data in Phase I/II Retreatment Studies of Tovaxin(R) for Multiple Sclerosis.
Next Article:GameStop Names Stanton Crenshaw PR Agency of Record.
Topics:



Related Articles
Millennium delivers validated target in prostate cancer for screening to Eli Lilly.
BIACORE'S NEW ADVANCED SYSTEM SET TO DRAMATICALLY REDUCE DRUG DISCOVERY AND DEVELOPMENT BOTTLENECKS; BIACORE LAUNCHES NEW HIGH PERFORMANCE ANALYTICAL...
HTS BIOSYSTEMS UNVEILS BETA 2 VERSION OF FLEX CHIP SYSTEM.
Pharmacopeia achieves success in collaboration with Berlex.
Pharmacopeia achieves milestone in collaboration with Berlex.
Pharmacopeia achieves milestone in collaboration with Berlex.
Pharmacopeia achieves research milestone in Celgene collaboration.
SRU Biosystems denies optical patent infringement claim.
Pharmacopeia p38 kinase collaboration with Squibb results in filing of IND.
Pharmacopeia collaborates with Schering-Plough on respiratory drug.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles